INTRODUCTION
There is controversy in the literature concerning the significance of apnea in preterm infants with respect to long-term outcomes. The relevant studies all date from before 1990, and have produced inconsistent results. One report described an increase in poor outcomes with a diagnosis of apnea, 1 another suggested that this was restricted to infants with obstructive apnea; 2 one small study showed no relationship 3 and one showed a relationship that disappeared when correcting for other risk factors. [1] [2] [3] [4] The patients included date in some cases from the 1970s 4 and the consequences of apnea may be quite different in the current era of neonatology, as can be seen from the outcomes in one of the studies 1 where infants with severe apnea had a mortality of 70%.
Previous studies have generally treated apnea as a dichotomous variable, 3 (apnea, yes or no); however, almost all premature infants have apneic spells; 5 they simply vary in frequency, severity, and how long they persist during the hospitalization. Although some of the previous studies attempted to estimate the severity of the apnea, this also was treated as a dichotomous variable, a subjective division that may hide some of the information available. It is biologically plausible that frequent hypoxic and bradycardic spells may lead to significant decrements in brain oxygen delivery during critical phases of brain growth and development, which may be followed by reoxygenation injury, and that this might affect long-term outcomes. It seems unlikely that frequent hypoxic/bradycardic spells are beneficial for cerebral function in the newborn; however, it is not clear whether individual apneic spells are long enough, or the disturbances in cerebral oxygen delivery severe enough, to actually cause permanent cerebral sequelae.
In a previous study, we showed that there was a positive relationship between the severity of apnea spells in former premature infants, recorded at the time of planned discharge from the NICU, and neurodevelopmental impairment. 6 In this study, we reasoned that there may be recurrent cerebral injury in infants during apneic spells, and we wished therefore to inquire whether an increase in the total frequency of apneas during the entire hospitalization was associated with worse neurological and developmental outcomes. Data on frequency and severity of apneas are difficult to obtain, indeed there is no agreement of what constitutes a more severe apnea. In our center, however, the number of days on which at least one apnea is noted in the medical record by the bedside nurses is collected for our database (''total apnea days''). We recognize that there are limitations in the clinical recording of apnea 7 with many apneas that are evident and possibly severe on objective recordings not being detected or recorded by the nursing staff. 8 However, we believed it was likely that the greater the number of apnea days recorded by the nursing staff, the greater the total number and severity of apneas, and thus, if the secondary effects of apnea are injurious to the developing brain, the greater the potential brain injury. We therefore performed a study combining information from the prospectively maintained database of the Royal Victoria Hospital, including apnea days, with further information obtained from chart review, and with results from neurodevelopmental assessments in infants at high risk of long-term compromise.
Our objective was to determine whether that there was a correlation between the number of days during hospitalization that apnea spells occur and 3-year outcomes. We hypothesized that increasing apnea days would correlate with an increasing risk of neurodevelopmental impairment, after correcting for other factors known to affect long-term neurological and developmental outcome. Secondary hypotheses were that increasing apnea days would correlate with an increasing risk of functional impairment as determined by the Vineland score, and that there would be a significant negative correlation between apnea days and scores on the Bayley Scales of Infant Development second edition (BSID).
METHODS
All infants born at less than 29 weeks gestation, and all infants less than 1250 g birth weight, are enrolled in the developmental followup program to be seen at a planned corrected age of 3 years. Infants born in the calendar years from 1990 to 1996 are included in the study. Owing to a low frequency of apnea we eliminated a very small number of severely SGA infants with a birth weight <1250 g but a gestational age Z32 weeks. The following data were abstracted from the database: antenatal information; including years of maternal education, antenatal steroid use, route of delivery, birth weight, gestation, and sex; clinical data; including Apgar scores, duration of mechanical ventilation and oxygen therapy, intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL), and postnatal steroid use. Growth parameters entered included birthweight for gestation at birth (as a ratio between actual weight and the 50th percentile), body weight and length for postmenstrual age at discharge and head circumference at discharge.
The number of days that one or more apneas were noted by the nursing staff was derived from the chart at the time of discharge for entry into the database, the ''total apnea days''. This was derived from the daily record of vital signs maintained during hospitalization by the nurses. Apneas occurring during feeds were included. Apneas are usually detected in clinical practice by the occurrence of bradycardia detected by the triggering of alarms, which are usually set in our nursery to alarm when the heart rate is less than 100, or by the occurrence of desaturation, the low saturation alarms usually being set to 84%. Thus the apneas recorded by our nursing staff are usually those with bradycardia or with desaturation. The use of respiratory stimulants was noted in the database, but not duration of therapy or dose. The stimulant most frequently used during this period was caffeine, with occasional use of theophylline or aminophylline. If an infant was intubated or received continuous positive airway pressure (CPAP) primarily as a treatment for apnea that was recorded in the database.
There were no infants with congenital heart disease requiring neonatal surgery in this cohort, infants with severe intraventricular hemorrhage were included, there were no infants with posthemorrhagic hydrocephalus requiring a shunt. Infants with known chromosomal anomalies were excluded. Follow-up procedures include several visits during the first 18 months of life, and then a visit at 3 years corrected age where a medical history, including hospitalizations and recurrent apnea or ALTE after discharge, anthropometry and full pediatric examination is performed by a physician with special interest in neonatal followup. A developmental assessment, using the Bayley Scales of Infant Development (BSID, 2nd ed) is administered by a certified developmental psychologist. The BSID provides a mental developmental index score (MDI) and a psychomotor index score (PDI), with a standard deviation of 15. A score of less than 50 was recorded as 50 for the analysis; infants who were untestable because they were too severely disabled were also recorded as having scores of 50.
At the time of follow-up, the parents were administered a semistructured interview where the Vineland Adaptive Behaviour Scale (VABS) was completed. This assessment examines functional abilities of infants in four areas: communication skills, daily living skills, socialization, and motor skills. The scale is constructed with a mean of 100 and a standard deviation of 15.
After reviewing the available information it was clear that apneas were recorded by the nursing staff whether the infants was intubated or extubated. Sudden acute desaturations and bradycardias during assisted ventilation were interpreted as apneas. 9, 10 It is likely that ''apneas'' recorded during mechanical ventilation are different, either in duration or in terms of its consequences, from apnea occurring during periods when respiration was not mechanically supported. For example, apneic spells during assisted ventilation may not lead to such severe hypoxia, also, the assisted breaths during these apneas modify the heart rate response. 10 Furthermore, the duration of assisted ventilation independently correlates with the frequency of developmental disability. Thus, the hospital records were obtained in order to determine the number of days that the infants had recorded bradycardias during assisted ventilation and the number of days of apnea when the infant was either not ventilated or was receiving nasal CPAP. This was performed using the same nursing record of vital signs as used for the original count of apnea days. This also served as a secondary check to confirm the accuracy of the initial count of apnea days entered into the database.
Ethical review board approval was obtained for retrieving information from the hospital records.
Analysis Independent variables were screened for associations with outcomes using univariate statistics. If there were possible associations (p<0.10) the variables were included in the multivariate analysis. Multiple logistic regression and multiple linear regression were then used to determine relationships with dichotomous or continuous outcomes respectively.
Independent variables examined were all those listed above. Growth retardation was entered as a birth weight ratio less than 0.75 (Yes or No), which is equivalent to the third percentile. Total apnea days (i.e., days when at least one apnea or bradycardia was noted, regardless of whether or not the infant was intubated), ventilator days (i.e., duration of assisted ventilation via endotracheal tube), apnea days when extubated, and ventilator days plus apnea days extubated were all examined. They were not entered into the same model because of the obvious interactions between these terms. They were therefore entered separately in the models and we report whichever of these variables had the strongest association with each of the outcomes.
Dependent variables tested were neurodevelopmental impairment (dichotomous, defined as either a Bayley MDI or PDI <70 or cerebral palsy or blindness), functional impairment by Vineland score (dichotomous, a score on any one of the four Vineland scales <70), and Bayley Developmental Quotient MDI and PDI (as continuous variables).
RESULTS

Patient Population
In total, 239 infants of <1251 g birthweight and <32 weeks gestation survived their initial hospitalization and were therefore enrolled in the follow-up program during the years of interest. Of these, two were known to have died prior to the 3-year follow-up appointment, and 62 were not seen for follow-up at 3 years. In all, 175 infants were therefore assessed for follow-up at a mean of 37 months corrected age (from 32 to 43 months), birth weight of these infants was between 450 and 1430 g, gestation mean ¼ 27.6 weeks (SD 2.2). A total of 29 infants had a birthweight ratio less than 0.75. There were no statistically significant differences between those seen for follow-up and those lost, in birthweight, birthweight ratio, antenatal steroid use or apnea days.
A total of 172 infants (98.3%) had recorded apneic spells; the median number of days on which at least one apnea was recorded in the hospital chart was 23 days (interquartile range 14 to 33), 143 of these children received respiratory stimulants, 56 were ventilated primarily for apnea at some time during their hospitalization. Infants who did not receive respiratory stimulants had a mean of 11.2 (SD 9) apnea days, while infants treated with respiratory stimulants had a mean of 27.9 (16) days. The total duration of intermittent mandatory ventilation (IMV) during hospitalization, for all causes, had a median of 18 days (interquartile range 0 to 39). Other patient descriptors are shown in Table 1 .
A total of 22 infants had at least a grade 2 IVH, 5 had an intracerebral hemorrhage. Infants with Zgrade 2 IVH did not have significantly more apnea days (mean 28, SD 18, days) than those without IVH (mean 25, SD 16, days, unpaired t-test, p ¼ NS). Duration of assisted ventilation was longer in those with IVH, mean 38 (SD 23) days than those without 20 (SD 23) days, unpaired t-test, p<0.005. There were four infants with cystic PVL, an inadequate number for analysis.
Follow-up Information
BSID test results were the following: mean MDI (n ¼ 129 tested) was 91.5 (SD 16) and PDI was 91.5 (SD 15); 6% had an MDI <70 and 6% a PDI <70. Six infants did not attend for the Bayley assessment before 48 months but were seen at 5 years of age and had Stanford-Binet IQ tests; all had normal 3-year neurological examinations and IQ results above the mean minus 2 SD and were considered nonimpaired. Four other infants were too severely limited to be tested using the Bayley, and are recorded as impaired. Seven others were functioning normally by parental report, had a normal neurological examination and a normal result on the Vineland assessment, and parents refused cognitive assessment; these infants were recorded as nonimpaired. In total, 172 infants had a full neurological assessment at 3 years of age.
The total number of children with at least one impairment (Bayley MDI or PDI <70, cerebral palsy or blindness) was 41. In all, 27 infants had an abnormal neurological examination, 27 were cognitively impaired (BSID<70) and one was severely visually impaired. A total of 13 infants had both cognitive impairment and an abnormal neurological examination, and the infant with severe visual impairment was also cognitively impaired and had a motor abnormality.
The distribution of neurodevelopmental impairment by gestational age is shown in the Figure 1 . On univariate analysis, impairment was associated with gestation, sex, years of maternal schooling, total apnea days, ventilator days, apnea days extubated plus ventilator days, and postnatal steroids (Tables 1 and 2 ). Using forwards conditional multiple logistic regression, apnea days extubated plus ventilator days and sex were the only significant correlates with neurodevelopmental impairment. The model was highly significant, p<0.001, and correctly classified 79.4% of cases. Female sex had an odds ratio of 0.27 (95% CI 0.12, 0.61) for neurodevelopmental impairment, and apnea days extubated plus ventilator days had an odds ratio of 1.023 (95% CI 1.007, 1.039) for each additional day either on a ventilator or with apnea after extubation. Alternative models with either total apnea days, or ventilator days, in place of ventilator plus apnea days extubated, were not as strongly significant (p<0.01 for both models).
The Bayley MDI was significantly associated by univariate analysis only with total apnea days, and the use of postnatal steroids. Using multiple linear regression only the use of postnatal steroids was significantly correlated with Bayley MDI scores (multiple linear regression): p ¼ 0.004, r 2 ¼ 0.062. The regression coefficient showed that use of postnatal steroids was associated with an average decrease in MDI score of 7.7 points.
The Bayley PDI was significantly associated by univariate analysis with postnatal steroid use, years of maternal schooling, sex and either apnea days, or apnea days extubated plus ventilator days. By multiple linear regression, sex, postnatal steroids and apnea days plus ventilator days were significantly correlated with PDI scores: p<0.001, r 2 ¼ 0.169. The partial regression coefficients showed that male sex was associated with a PDI 9.0 points less than female cases, the use of postnatal steroids was associated with a score reduced on average by 5.2 points, and each additional day either on a ventilator or with apnea was associated with a decrease in the PDI by 0.14 points.
Scores less than 70 on any of the four scales of the Vineland score (n ¼ 141) were found between 5 and 14% of the time. If any one of the VABS domains scored below 70, the infant was considered to be functionally impaired. This was found in 17% of the infants; the only variables associated with functional impairment on the VABS on univariate analysis were growth retardation (birth weight ratio less than 0.75) and apnea days (either total apnea days, or ventilator days plus apnea days extubated). By multiple logistic regression growth retardation was no longer significant, and the strongest associate of impairment was total apnea days, odds ratio 1.12 (95% CI 1.10, 1.14) for each additional day with an apnea, p<0.05.
There were a number of tested variables that were not significantly associated with any of these outcomes, including discharge weight ratio, and antenatal steroids.
CONCLUSIONS
We have demonstrated that there is a statistical association between neurodevelopmental impairment and an increase in the number of days of hospitalization during which apnea/bradycardia episodes were recorded by the nursing staff. This association persists after correcting for multiple other known risk factors, including postnatal steroids, and gender and taking into account the duration of assisted ventilation. This is the first study of the neurodevelopmental outcome effects of apnea in premature infants that has used information derived from daily nursing records of apnea. Previous studies that have addressed this issue have classified infants as being with or without apnea. However, apnea is almost universally present in the preterm infant, varying only in the frequency and severity of the apneic episodes. Consistent with this postulate is the finding that only three of the 175 infants in this data set did not have any apnea recorded in their hospital records. Some of the previous studies have also been underpowered, with for example, the outcome of 17 infants with severe apnea being reported as not significantly different from five control infants, 3 despite a trend to lower developmental scores.
Apnea spells vary in severity, but there is no general agreement on what truly constitutes a more ''severe'' form of apnea, whether it is deeper desaturation, more marked bradycardia or a combination of the two. Even the exact meaning of ''severe'' in this circumstance is not clear: does it mean a greater degree of predicted cerebral deoxygenation or an increased risk of being reintubated? We made the pragmatic choice to use the available information within the database; that is, the number of days during which at least one apnea was recorded by the nursing staff. We recognize that this information is also flawed. It has been shown that the nursing record is far from including all apneic spells, with only about 50% of apneas being recorded by the bedside caregivers. 7 In clinical practice, the apnea alarm from the impedance trace is of limited usefulness. It is sometimes difficult to obtain a good signal with minimal cardiac artefact. The alarm will also not be activated during obstructive apnea, nor during mixed apnea unless the central portion of the apnea exceeds the alarm limit, which is most often either set to 20 seconds or switched off. Apnea that does not lead to bradycardia or desaturation is, in any case, of uncertain significance. Although apneas are frequently ''missed'' by current monitoring and recording techniques, it seems likely that there is a direct correlation between the true frequency of apneas and the numbers recorded in the hospital chart. Thus, it seems likely that infants with more apnea days did, in general, have more days on which apnea actually occurred, and thus more actual apnea spells during their hospitalization than infants with fewer apnea days.
The influence of apnea days was statistically significant in all our models; this was not due to the more immature infants having more days in hospital and thus more days of opportunity to have apneas. Indeed, gestational age was not a statistically significant predictor of poor outcomes.
Our study has a number of limitations. Apnea was recorded during routine record keeping by the nursing staff, which is known to under-report apnea. 7 Furthermore, the severity of the individual apnea spells cannot be determined from this data set. It is clear, for instance, that some apneas are associated with more severe and prolonged bradycardia than others; however, without prolonged objective recording we did not consider that any further description of the apneas would be helpful. Furthermore, an infant with one apnea during a 24-hour period, and an infant with several, are both considered to have an apnea day. Although it is common experience that infants with many apneas per day are more likely to persistently have apneas every day, and therefore will continue to have apneas for a greater total of apnea days than infants with few apneas, there are no published data we could find to confirm this. The rate of follow-up at 3 years is less than we would have wished; it may be that infants who were followed up during this period, and those who were not, could have had substantially differing relationships between apnea days and outcomes. However, the relationships that we found were statistically significant, which implies that the relationship is probably real for the entire population, as long as there was no systematic difference between our sample and the population as a whole.
During an 80-day hospitalization a preterm infant could easily have an average of more than 12 apneas per day, and a total of more than 1000 hypoxic and bradycardic episodes. These episodes may well cause a substantial reduction in cerebral oxygen delivery, followed by reoxygenation. The frequent use of oxygen during resuscitation of apnea may in fact lead to hyperoxia. Such hypoxia/reoxygenation injury could well generate oxygen free radicals and lead to cellular injury in the developing cortex. 11 Thus, there is at least the potential for apneic spells to cause cerebral injury.
It is also certainly possible that pre-existing cerebral injury may cause an increase in apneic spells. However, in our data set, although hemorrhage was a risk factor for some adverse outcomes, apnea days were not increased in infants with severe hemorrhages, although the duration of assisted ventilation was increased. The question of whether apnea is a cause or a result of cerebral dysfunction in the preterm infant (or whether the association is merely apparent due to both apnea and poor outcome being associated with other variables) will not be answered from retrospective studies such as this one. Indeed as apnea is almost universal, perhaps a more useful question is whether specific therapies for apnea improve the long-term outcome. However, the therapies currently in use may themselves have toxic effects, 12 and thus complicate the interpretation of the results of a randomized trial. It is not even clear that methylxanthines cause a sustained effect in reduction of apneic spells in the preterm, short-term ''before and after'' studies show a reduction in apnea frequency coincident with the introduction of caffeine, 13 but a placebocontrolled study of aminophylline showed that apnea was only reduced therapy transiently after commencement of therapy. 14 The current study cannot answer the question of the potential toxic or beneficial effects of caffeine because we do not have information about the duration of caffeine treatment or dose, and respiratory stimulants were very frequently used in this population. Future therapies for apnea, which are effective in the longer term and free of potential developmental toxicities, should allow the determination of the importance of apnea in neurodevelopment. Nasal CPAP 15 and perhaps nasal ventilation 16 decrease apneic spells. Perhaps a future trial should determine whether very prolonged treatment with CPAP will reduce the overall total number of hypoxic/bradycardic spells in the newborn, and thus have the potential to improve long-term outcomes.
